美女免费一级视频在线观看
The Trump administration backed off 100% pharma tariffs that were threatened to start this week. The tariffs have not yet gone into effect today, but the administration said that it is looking into preparing tariffs for companies who don’t manufacture products in the U.S. (STAT News)
U.S. insurers have reduced their Medicare Advantage operations in 2026. CVS Health said its Aetna insurance business will pull back and operate in 100 fewer countries than it did in 2025, and so will UnitedHealth. (Reuters)
The Food and Drug Administration will not accept any new drug applications during the government shutdown. The FDA said that its committed to retaining 86% of its staff. (Seeking Alpha)
How Trump’s DTC platform, TrumpRx, will work. On Tuesday, the administration announced TrumpRx, the first government direct to consumer platform for patients. But how will it actually work? (The Wall Street Journal)
Takeda is discontinuing its work on cell therapy. The move will result in a loss of about $394 million invested in the company’s gamma delta T-cell therapy program. (Endpoints News)
To read yesterday’s edition of Five things for pharma marketers to know, click here.